Concepedia

Publication | Open Access

Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial

DOIFull Paper Access

353

Citations

28

References

2018

Year

Helena W. Rodbard, Ildiko Lingvay, John H. Reed, Raymond de la Rosa, Ludger Rose, Danny Sugimoto, Eiichi Araki, Pei-Ling Chu, Nelun Wijayasinghe, Paul Norwood
The Journal of Clinical Endocrinology & Metabolism

Abstract

Semaglutide, added to basal insulin, significantly reduced HbA1c and body weight in patients with uncontrolled T2D vs placebo.

References

YearCitations

Page 1